-
Something wrong with this record ?
Upgrade Rate and Predictive Factors Associated With Breast Papillary Lesions on Core Biopsy: A Canadian Experience
T. Salisbury, A. Gurung, S. Koonmee, L. Ali, O. Ondic, R. Bhan, K. Pivovarcikova, O. Hes, R. Alaghehbandan
Language English Country United States
Document type Journal Article
- MeSH
- Biopsy, Large-Core Needle MeSH
- Humans MeSH
- Breast Neoplasms * diagnosis MeSH
- Papilloma * pathology MeSH
- Retrospective Studies MeSH
- Aged MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Canada MeSH
Background: Papillary lesions of the breast are a heterogeneous group, encompassing a wide range of lesions. The histologic distinction between papillary breast lesions remains challenging, especially on core biopsy specimens. Aim: This study aimed to determine the rate of upgrade to atypia or malignancy of biopsy-proven papillary lesions on surgical follow-up and to assess for factors associated with an upgrade in Greater Vancouver, BC, Canada. Materials and Methods: This is a retrospective population-based study of all breast papillary lesions diagnosed on core biopsy between 2017 and 2019 in the Fraser Health Authority in Greater Vancouver, Canada. Patients were retrieved from the laboratory information system. Patient demographics, histopathologic, and radiologic findings were analyzed. Results: A total of 269 specimens from 269 patients (mean 61.1 years), including 265 female and 4 male patients, were included in the study. Of the 269 specimens, 129 (48%) were intraductal papillomas and 140 (52%) were atypical papillary lesions. The overall upgrade rate among papillomas was 11.6% (15 of 129) on final excision. The mean age of patients diagnosed with papilloma on core biopsy was significantly younger than those with atypical papillary lesions (55.6 vs 66.1 years, P < .0001). Lesion size in patients with papillomas on core biopsy was significantly smaller than those with atypical papillary lesions (11.1 vs 15.1 mm, P = .001). The upgrade rates in patients <55 and ≥55 years were 4.9% and 13.2%. Size (P = .004) and atypia on core biopsy (P = .009) were significantly associated with upgrade. Older age (>55 years) (OR = 5.3, 95% CI: 1.04-27.08) was an independent predictor of upgrade among papillomas. Size, location, and Breast Imaging-Reporting and Data System (BI-RADS) radiologic categories in our study were not associated with predicting the upgrade of papillomas. Conclusion: Our data suggest that the risk of upgrade to atypia or malignancy is sufficient to warrant the excision of benign papillomas of any size in patients aged ≥55 years. In patients younger than 55 years, observation with close clinical and radiological follow-up without surgery may be sufficient. Our findings also support surgical excision of papillomas diagnosed on core biopsy when associated with atypia.
Department of Medicine Saba University School of Medicine The Bottom Saba Dutch Caribbean
Department of Pathology Carol Davila University of Medicine and Pharmacy Bucharest Romania
Department of Pathology Faculty of Medicine Charles University Plzen Czech Republic
Department of Pathology Faculty of Medicine Khon Kaen University Khon Kaen Thailand
Department of Pathology Faculty of Medicine The University of British Columbia Vancouver BC Canada
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24001200
- 003
- CZ-PrNML
- 005
- 20240213094432.0
- 007
- ta
- 008
- 240109s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1177/10668969221137515 $2 doi
- 035 __
- $a (PubMed)36437635
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Salisbury, Taylor $u Department of Pathology, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada
- 245 10
- $a Upgrade Rate and Predictive Factors Associated With Breast Papillary Lesions on Core Biopsy: A Canadian Experience / $c T. Salisbury, A. Gurung, S. Koonmee, L. Ali, O. Ondic, R. Bhan, K. Pivovarcikova, O. Hes, R. Alaghehbandan
- 520 9_
- $a Background: Papillary lesions of the breast are a heterogeneous group, encompassing a wide range of lesions. The histologic distinction between papillary breast lesions remains challenging, especially on core biopsy specimens. Aim: This study aimed to determine the rate of upgrade to atypia or malignancy of biopsy-proven papillary lesions on surgical follow-up and to assess for factors associated with an upgrade in Greater Vancouver, BC, Canada. Materials and Methods: This is a retrospective population-based study of all breast papillary lesions diagnosed on core biopsy between 2017 and 2019 in the Fraser Health Authority in Greater Vancouver, Canada. Patients were retrieved from the laboratory information system. Patient demographics, histopathologic, and radiologic findings were analyzed. Results: A total of 269 specimens from 269 patients (mean 61.1 years), including 265 female and 4 male patients, were included in the study. Of the 269 specimens, 129 (48%) were intraductal papillomas and 140 (52%) were atypical papillary lesions. The overall upgrade rate among papillomas was 11.6% (15 of 129) on final excision. The mean age of patients diagnosed with papilloma on core biopsy was significantly younger than those with atypical papillary lesions (55.6 vs 66.1 years, P < .0001). Lesion size in patients with papillomas on core biopsy was significantly smaller than those with atypical papillary lesions (11.1 vs 15.1 mm, P = .001). The upgrade rates in patients <55 and ≥55 years were 4.9% and 13.2%. Size (P = .004) and atypia on core biopsy (P = .009) were significantly associated with upgrade. Older age (>55 years) (OR = 5.3, 95% CI: 1.04-27.08) was an independent predictor of upgrade among papillomas. Size, location, and Breast Imaging-Reporting and Data System (BI-RADS) radiologic categories in our study were not associated with predicting the upgrade of papillomas. Conclusion: Our data suggest that the risk of upgrade to atypia or malignancy is sufficient to warrant the excision of benign papillomas of any size in patients aged ≥55 years. In patients younger than 55 years, observation with close clinical and radiological follow-up without surgery may be sufficient. Our findings also support surgical excision of papillomas diagnosed on core biopsy when associated with atypia.
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a biopsie dutou jehlou $7 D062005
- 650 12
- $a papilom $x patologie $7 D010212
- 650 12
- $a nádory prsu $x diagnóza $7 D001943
- 651 _2
- $a Kanada $7 D002170
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Gurung, Ananta $u Department of Pathology, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada
- 700 1_
- $a Koonmee, Supinda $u Department of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand
- 700 1_
- $a Ali, Leila $u Department of Pathology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
- 700 1_
- $a Ondic, Ondrej $u Department of Pathology, Faculty of Medicine, Charles University, Plzen, Czech Republic
- 700 1_
- $a Bhan, Rohan $u Department of Medicine, Saba University School of Medicine, The Bottom, Saba, Dutch Caribbean
- 700 1_
- $a Pivovarcikova, Kristyna $u Department of Pathology, Faculty of Medicine, Charles University, Plzen, Czech Republic
- 700 1_
- $a Hes, Ondrej $u Department of Pathology, Faculty of Medicine, Charles University, Plzen, Czech Republic
- 700 1_
- $a Alaghehbandan, Reza $u Department of Anatomic Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA $1 https://orcid.org/0000000267085032
- 773 0_
- $w MED00002376 $t International journal of surgical pathology $x 1940-2465 $g Roč. 31, č. 7 (2023), s. 1206-1216
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36437635 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240109 $b ABA008
- 991 __
- $a 20240213094429 $b ABA008
- 999 __
- $a ok $b bmc $g 2049672 $s 1210894
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 31 $c 7 $d 1206-1216 $e 20221127 $i 1940-2465 $m International journal of surgical pathology $n Int. j. surg. pathol. $x MED00002376
- LZP __
- $a Pubmed-20240109